StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Alendronate Sodium

HCID 23681107
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
121268-17-5
Standard-SMILES
NCCCC(O)(P(=O)([O-])O)P(=O)(O)O.O.O.O.[Na+]
InChIKey
DCSBSVSZJRSITC-UHFFFAOYSA-M
Summenformel
C4H18NNaO10P2
Durchschnittliche Molmasse
325,12 g/mol
Monoisotopische Masse
325,03036332

Überblick

Alendronate sodium trihydrate is a hydride that is the trihydrate of alendronate sodium. It has a role as an EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor and a bone density conservation agent. It is a hydrate and an organic sodium salt. It contains an alendronate(1-).

Namen und Bezeichner

Bevorzugter Name
Alendronate Sodium
IUPAC
sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate;trihydrate
Englischer Name
Alendronate sodium trihydrate
Summenformel
C4H13NO7P2.3H2O.Na
Molmasse
326.13

Namen und Synonyme

Alendronate sodium trihydrateALENDRONATE SODIUMAdronatAlendrosSODIUM ALENDRONATE TRIHYDRATEAdrovanceSodium alendronateVantavoDTXSID7047801Alendronic acid monosodium salt trihydrate2UY4M2U3RAFosavance
Weitere Namen anzeigen
SodiuM Alendronate HydrateFosamaxBifosaNeoBonFosamsx
OnclastPhosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt, trihydrateG-704,650sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate trihydrateAlendronate (as sodium)MK-217Monosodium (4-amino-1-hydroxybutylidene)bisphosphonate trihydrateCHEBI:2566

Datenbank-Bezeichner

CAS
121268-17-5
PubChem CID
23681107
DTXSID
DTXSID7047801
ChEMBL
CHEMBL2367465、CHEMBL675
ChEBI
CHEBI:2566
UNII
2UY4M2U3RA
EC Number

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
167 Ų
H-Brücken-Donoren
8
H-Brücken-Akzeptoren
11
Frei drehbare Bindungen
5
Schwere Atome
18
Formalladung
0
Komplexität
293

Experimentelle und physikochemische Eigenschaften

Human Drugs · 4 Einträge

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Physikochemische Eigenschaften

Schmelzpunkt
245 °C · 245°C
storage temp.
-20 °C · -20°C
Löslichkeit
10 mg/mL · water, double-distilled: 10 mg/mL
Aggregatzustand
solid
Farbe
white
Wasserlöslichkeit
10 mg/ml · Soluble in water at 10mg/ml
Merck
14 · 14,229
Stabilität
Store in freezer
InChI
InChI=1S/C4H13NO7P2.Na.3H2O/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;;;;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);;3*1H2/q;+1;;;/p-1
InChIKey
NKENDYHBVCKCNL-UHFFFAOYSA-M
SMILES
C(O)(CCCN)(P([O-])(=O)O)P(=O)(O)O.[Na+].O.O.O

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 1.8% (2 of 110) of reports.

Danger

H302 (98.2%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P318, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 110 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

Gefahrenhinweise

Hazard Classes and Categories · 2 Einträge

Acute Tox. 4 (98.2%)

Acute Tox. 4 (100%)

Toxikologische Informationen

Exposure Routes · 1 Eintrag

Relative to an intravenous (IV) reference dose, the mean oral bioavailability of alendronate in women was 0.7% for doses ranging from 5 to 40 mg when administered after an overnight fast and two hours before a standardized breakfast. Oral bioavailability of the 10 mg tablet in men (0.59%) was similar to that in women (0.78%) when administered after an overnight fast and 2 hours before breakfast.

Toxicity Summary · 1 Eintrag

The action of Alendronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Alendronate also targets farnesyl pyrophosphate (FPP) synthase. Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isoprenoid diphosphate lipids, thereby inhibiting FPP synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are essential for the post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins. This activity inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass.

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

There is no evidence that alendronate is metabolized in humans or animals. Route of Elimination: Following a single IV dose of [14C]alendronate, approximately 50% of the radioactivity was excreted in the urine within 72 hours and little or no radioactivity was recovered in the feces. Half Life: >10 years

FDA Pharmacological Classification · 4 Einträge

ALENDRONATE SODIUM

Diphosphonates [CS]; Bisphosphonate [EPC]

ALENDRONATE SODIUM TABLET

Bisphosphonate [EPC]; Diphosphonates [CS]

MeSH Pharmacological ClassificationAgents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

Verwendung und Herstellung

UsesFor the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women.
Anwendungen · 1 Eintrag

VerwendenAlendronate sodium trihydrate is used as a bone resorption inhibitor, farnesyl diphosphate synthase inhibitor and CD45 protein tyrosine phosphatase inhibitor. A robust inhibitor of bone resorption that induces apoptosis. Alendronate inhibits the migration and invasion of PC-3 cells (sc-2220) by interfering with the mevalonate pathway. Additionally, Alendronate, Sodium Salt is an inhibitor of CD45RC and MMP.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Phosphorige Säure-trichlorid

Zugehörige Reaktionen

8
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 128913
HRID 128913als Edukt
Reaktionsgleichung von HRID 651848
HRID 651848als Edukt
Reaktionsgleichung von HRID 871804
HRID 871804als Edukt
Reaktionsgleichung von HRID 871805
HRID 871805als Edukt
Reaktionsgleichung von HRID 871806
HRID 871806als Edukt
Reaktionsgleichung von HRID 1062844
HRID 1062844als Edukt
Reaktionsgleichung von HRID 1676015
HRID 1676015als Produkt
Reaktionsgleichung von HRID 2122077
HRID 2122077als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
601-766-4、950-815-9
CAS Datenbank
121268 · 121268-17-5(CAS DataBase Reference)
Signs and SymptomsAlendronate can damage the esophagus both by toxicity from the medication itself and by nonspecific irritation secondary to contact between the pill and the esophageal mucosa, similar to other cases of "pill esophagitis."
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Alendronate sodium

vLess-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

wgk
3
hs_code
29310095
RTECS-Nr.
SZ6523500
risk_code
22-36/37/38
hazard_code
Xn,Xi
safety_code
26-36-60
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 Oral
4-Aminobuttersure
Phosphorigsure
Alendronic acid
2-Pyrrolidon
Natriumhydroxid
Natriumcarbonat

Ergänzende Hinweise

DefinitionChEBI: A hydride that is the trihydrate of alendronate sodium